Skip to main content
Clinical Trials/JPRN-UMIN000017628
JPRN-UMIN000017628
Recruiting
Phase 3

A phase III study of minimally invasive versus open esophagectomy for thoracic esophageal cancer (JCOG1409, MONET trial) - A phase III study of minimally invasive versus open esophagectomy for thoracic esophageal cancer (JCOG1409, MONET trial)

Japan Clinical Oncology Group (JCOG)0 sites300 target enrollmentMay 20, 2015

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
clinical stage I/II/III (excluding T4) thoracic esophageal cancer
Sponsor
Japan Clinical Oncology Group (JCOG)
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 20, 2015
End Date
May 20, 2027
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japan Clinical Oncology Group (JCOG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. 2\) Infectious disease with systemic therapy indicated. 3\) Body temperature of 38 or more degrees Celsius. 4\) Pregnancy, possible pregnancy, within 28 days after delivery or breast\-feeding. 5\) Severe psychiatric disease. 6\) Continuous systemic steroid or immune\-suppressive drug therapy. 7\) Unstable angina pectoris, or history of myocardial infarction within six months. 8\) Severe pulmonary fibrosis or emphysema. 9\) Poorly controlled hypertension. 10\) Poorly controlled diabetes mellitus in spite of continuous use of insulin.

Outcomes

Primary Outcomes

Not specified

Similar Trials